Gruppo, Levey, and CompanyGruppo, Levey, and Company
Company OverviewTeamIndustry ExpertiseServicesTransaction ExperienceNews

matthew acierno

Associate

Matthew Acierno joined Gruppo, Levey & Co. in 2007 with four years experience in mergers, acquisitions and public and private financings. Prior to joining GLC, he was an Associate at Paramount BioCapital, a boutique investment bank, where he focused on the initiation and execution of M&A transactions and equity financings for North American biotechnology companies. From the initial identification of acquisition targets for buy-side clients, Mr. Acierno was involved in aspects of M&A transactions including analysis, due diligence, and negotiation. He was also actively involved in the firm’s capital raising efforts for public and private biotechnology companies with North American institutional investors.

At GLC, Mr. Acierno conducts financial, company, and valuation analyses, assists in the determination of client strategies and drafts offering memoranda and marketing materials in support of M&A and private financing transactions.

Mr. Acierno received a B.S. in Finance and Economics from New York University’s Leonard Stern School of Business and an M.B.A. from the Richard Ivey School of Business.


Phone: 212-697-5753, Ext. 334

Claire Gruppo,
Co-Founder/Managing Director
Hugh Levey,
Co-Founder/Managing Director
Mark DeGennaro,
Managing Director
Marino Marin,
Managing Director
Harrison Sapru,
Managing Director
Jeff Weinberger, Principal
Edward McCabe,
Senior Vice President, Finance
Elizabeth Frankel,
Vice President
Antonia Ness,
Vice President
Matthew Acierno, Associate
Pamela Roux, Associate
John Bayne, Analyst
Leena Ngov, Analyst
Elliot Ross, Analyst
 
212.697.5753

Legal Notices | Privacy Policy

© 2007 Gruppo, Levey & Co., a member of FINRA/SIPC. All rights reserved.

Download the PDF brochure